Prevalence and genotype distribution of human papillomavirus in Zhengzhou, China, in 2016.,Archives of Virology

当前位置： X-MOL 学术 › Arch. Virol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prevalence and genotype distribution of human papillomavirus in Zhengzhou, China, in 2016.
Archives of Virology ( IF 2.7 ) Pub Date : 2020-01-06 , DOI: 10.1007/s00705-019-04515-3
Jinjin Liu ₁ , Shuhuan Ma ₁ , Chuan Qin ₁ , Suiling Zheng ₁ , Zhaoyun Chen ₁ , Yi Huang ₁ , Junli Xiong ₂ , Yuqi Huo ₁

Affiliation

In this study, the prevalence and genotype distribution of human papillomavirus (HPV) in 49,793 women aged 25-64 years were determined by fluorescent real-time polymerase chain reaction (PCR) assay. HPV was detected in 6,020 women, giving a prevalence of 12.09% (6020/49,793). Single and multiple infections accounted for 71.81% (4323/6020) and 28.19% (1697/6020) of total infections, respectively. The most commonly found genotypes were HPV52 (19.90%, 1198/6020) and HPV16 (19.17%, 1154/6020), followed by HPV58 (13.11%, 789/6020), HPV81 (10.10%, 608/6020) and HPV56 (9.00%, 542/6020). The prevalence of HPV increased with age and was highest in the 54- to 64-year-old age group. The genotypes covered by the nonavalent HPV vaccine accounted for 39.32% (2367/6020) and 22.81% (1373/6020) of the total monoinfections and polyinfections, respectively. This study indicates a high HPV infection rate in women in the city of Zhengzhou and a large percentage of women are infected with single or multiple high-risk HPV genotypes that cannot be prevented using the current nonavalent HPV vaccine. Vaccines incorporating more HPV genotypes and extended age coverage for the current nonavalent vaccine might be necessary to better prevent HPV-related cervical cancer.

更新日期：2020-01-06

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>